Onaka Hiroyasu, Taniguchi Shin-ichi, Ikeda Haruo, Igarashi Yasuhiro, Furumai Tamotsu
Biotechnology Research Center, Toyama Prefectural University, Kosugi, Toyama 939-0398, Japan.
J Antibiot (Tokyo). 2003 Nov;56(11):950-6. doi: 10.7164/antibiotics.56.950.
A novel shuttle integration cosmid vector (pTOYAMAcos), based on pKU402, and shuttle integration vectors (pTYM18 and pTYM19) were constructed for the cloning of actinomycete DNA and its heterologous expression. These vectors contain oriT of an IncP transmissible plasmid in order to transfer genes by conjugation from Escherichia coli to actinomycetes, and they also contain int derived from actinophage phiC31 in order to integrate site-specifically into the chromosomal DNA. pTOYAMAcos contains the lambdacos site to promote packaging of vectors containing 35 to approximately 45-kb DNA fragments into lambda particles. pTYM18 and pTYM19 contain kanamaycin and thiostrepton resistance genes, respectively, and have multiple cloning sites including EcoRI and HindIII sites, which are available for blue/white screening in E. coli. To demonstrate the utility of these vectors, we expressed the entire gene cluster for rebeccamycin biosynthesis from Lechevalieria aerocolonigenes using pTOYAMAcos and detected rebeccamycin production in transformed S. lividans. In addition, we demonstrated the utility of pTYM 19 in a gene-disruption complementation test. L. aerocolonigenes deltarebC strain, which is defective in rebeccamycin production because of a rebC deletion, was restored to rebeccamycin production by complemention by rebC cloned in pTYM 19.
构建了一种基于pKU402的新型穿梭整合黏粒载体(pTOYAMAcos)以及穿梭整合载体(pTYM18和pTYM19),用于放线菌DNA的克隆及其异源表达。这些载体含有IncP可转移质粒的oriT,以便通过接合作用将基因从大肠杆菌转移至放线菌,并且它们还含有源自噬菌体phiC31的int,以便位点特异性整合到染色体DNA中。pTOYAMAcos含有λ黏粒位点,以促进将含有35至约45 kb DNA片段的载体包装到λ颗粒中。pTYM18和pTYM19分别含有卡那霉素和硫链丝菌素抗性基因,并具有多个克隆位点,包括EcoRI和HindIII位点,可用于在大肠杆菌中进行蓝/白筛选。为了证明这些载体的实用性,我们使用pTOYAMAcos表达了来自产气栖热放线菌的瑞贝克霉素生物合成的完整基因簇,并在转化的变铅青链霉菌中检测到瑞贝克霉素的产生。此外,我们在基因破坏互补试验中证明了pTYM 19的实用性。由于rebC缺失而在瑞贝克霉素生产中存在缺陷的产气栖热放线菌deltarebC菌株,通过克隆在pTYM 19中的rebC互补恢复了瑞贝克霉素的生产。